Kedar Purushottam Phadke
Geen lopende functies
Loopbaan van Kedar Purushottam Phadke
Eerdere bekende functies van Kedar Purushottam Phadke
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| THERMAX LIMITED | Compliance Officer | 08-08-2017 | 19-08-2021 |
| Investor Relations Contact | 08-08-2017 | 19-08-2021 | |
| Bedrijfssecretaris | 08-08-2017 | 19-08-2021 | |
Emcure Pharmaceuticals Ltd.
 Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Bedrijfssecretaris | 19-11-2010 | - |
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Algemeen Adviseur | 01-12-2009 | - |
| Bedrijfssecretaris | 01-12-2009 | - |
Statistieken
Internationaal
| India | 4 |
Operationeel
| Corporate Secretary | 3 |
| General Counsel | 1 |
| Compliance Officer | 1 |
Sectoraal
| Producer Manufacturing | 3 |
| Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| KIRLOSKAR PNEUMATIC COMPANY LIMITED | Producer Manufacturing |
| THERMAX LIMITED | Producer Manufacturing |
| Bedrijven in privébezit | 1 |
|---|---|
Emcure Pharmaceuticals Ltd.
Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |
